Groundbreaking Technology: Micro Biosensor Chip Capable of Simultaneously Detecting Multiple Biomarkers

Groundbreaking Technology: Micro Biosensor Chip Capable of Simultaneously Detecting Multiple Biomarkers 

LIVE EVENT for EVERYONE (Scientists, Clinicians, Investors, Industry, Government) The recording will only be available for Technology Evaluation Consortium™ members.

Are you a pharma or biotech industry member?

The Signature Square program has been designed by the industry, for the industry.

The Signature Square program has been designed by the industry, for the industry.

It is your opportunity to evaluate and provide feedback on an exclusive, one-of-a-kind technology that provides an earlier detection of physiological biomarkers related to diseases and exposure to toxic chemicals, to name a few.

These sensors use highly sensitive and selectively, functionalized, single-walled carbon nanotubes (s-SWCNTs) that detect D-glucose, L-lactate, Urea, OTC (Oxytetracycline), E. coli, and Adenovirus with very high sensitivity, selectivity, stability and repeatability. This micro biosensor chip is also capable of simultaneously detecting multiple biomarkers (in vitro and in vivo) with a detection limit that’s 200 times lower than current technology.

These flexible carbon Nanotube (s-SWCNT) conductance-based sensor platforms can be used for instantaneous measurement of various pathogens, and for monitoring physiological parameters of the human body for applications in the wearable electronics, and also for health monitoring.

This exclusive opportunity provides you with a front-row seat to hear about new technology and science. Current member companies in the Signature Square program include organizations like Pfizer, AbbVie, Amgen and Janssen, along with many others.

However, on a trial basis, we are allowing new industry participants, and other scientists, clinicians & organizations, to evaluate this technology and take part in this webinar entitled “Groundbreaking Technology: Micro Biosensor Chip Capable of Simultaneously Detecting Multiple Biomarkers” on Monday, September 28th at 11am EST.

Be a part of this exclusive webinar by clicking HERE.

 

PANELISTS
	SPEAKER: Dr. Ahmed Busnaina Director Center for High-rate Nanomanufacturing Northeastern University
	SPEAKER: Dr. April Gu Associate Professor Northeastern University
	MODERATOR: Dawn Van Dam President & CEO One Million Solutions in Health™